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Title: Let’s talk about sex: Does language constitute a barrier to women reporting and receiving 
treatment for dyspareunia in the Spanish speaking community? 
Purpose: To identify the prevalence of dyspareunia and sexual dysfunction within the 
population of English and Spanish speaking women visiting outpatient clinics and to compare 
the rates of patients discussing symptoms of painful sex with healthcare providers between 
language groups.  
Design: Cross-sectional survey, descriptive study 
Setting: The University of Kansas Obstetrics and Gynecology Clinic and affiliated Jay Doc Free 
Health Clinic 
Patients: Convenience sample of English and Spanish speaking women, ages 18-45  
Methods: Subjects completed anonymous surveys in either English or Spanish. The surveys 
were administered through REDCap and included the validated questionnaires for the Visual 
Analog Scales (VAS) for pain, Female Sexual Function Index (FSFI) and Patient Global 
Impression of Improvement (PGI-I). Data on demographics and discussion of pain with 
healthcare providers was also collected. The prevalence of sexual dysfunction and dyspareunia 
was calculated for each cohort and the rate of discussion of dyspareunia was identified for each 
language. Prevalence, FSFI domain scores and discussion rates were compared between groups 
using t-test and chi-square analysis. 
Main Result: A total of 160 women were surveyed (107 English speaking and 53 Spanish 
speaking). The prevalence of dyspareunia was found to be 42.06% and 28.30% in the English 
and Spanish cohorts respectively (p=0.087) and the rates of discussion of dyspareunia was 
significantly higher in the English cohort compared to the Spanish (20.56% vs 5.66%, 
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p=0.011).The prevalence of sexual dysfunction, based on an FSFI score <26.55, was found to be 
46.73% and 62.26% in English and Spanish cohorts respectively (p=0.048). When comparing the 
individual FSFI domains, scores for desires, arousal, lubrication, orgasm and pain were 
significantly higher in the English cohort (p<0.05).  
Conclusion: Our main outcome measures show a significantly higher prevalence of dyspareunia 
and rate of discussion in the English cohort compared to the Spanish cohort. The FSFI score and 
5 out of 6 of individual domain scores were significantly higher in the English cohort. A 
significantly larger portion of the Spanish speakers scored below 26.55, signifying sexual 
dysfunction. Our measurements for sexual dysfunction and dyspareunia prevalence are higher 
than estimates found in literature. We encourage continuing research to obtain a larger sample 
size for expanded analysis. The differences in Spanish speakers low FSFI scores compared to 
their lower prevalence of subjective dyspareunia requires more investigation. Future studies 
should investigate specific barriers in communication between Spanish speakers and clinicians 
when discussing sexual function and pain.   
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1 Literature Review 
1.1 Significance of Dyspareunia 
 Sexual dysfunction is estimated to impact 43% of women in the US[1]. This is a greater 
percentage than men. Women experiencing sexual dysfunction can suffer a variety of 
complications with desire, arousal, achieving climax, anxiety about sexual performance, pain 
with sex or not finding sex pleasurable. These problems can greatly impact quality of life and 
may be linked to other comorbidities, such as anxiety and depression. Despite the significance of 
the condition, patients can frequently go undiagnosed and are left untreated.  
 Dyspareunia is a specific type of sexual dysfunction that refers to pain with vaginal 
penetration. It is estimated that 8-22% [2] of women will experience these symptoms at some 
point in their lives. There is concern that the true prevalence is higher than estimates found in 
literature [3]. This condition can impact women of all ages. Prior studies included women as 
young as 15 and as old as 74[3, 4]. In a US based study 21% of women aged 18-29 and 8% of 
women aged 50-59 experienced dyspareunia[1]. The incidence risk ratio is estimated to be 9.3 
when comparing younger age women (20-29 years) to older (50-60 years)[5]. While the exact 
percentages differ between studies, there is a common theme of higher prevalence for women in 
their reproductive years[2, 5]. 
 There are many etiologies for the source of pain [6]. In younger women we frequently 
suspect problems with endometriosis, fibroids or hormonal imbalance. There may also be issues 
of vulvodynia, chronic vaginitis, levator spasm or vaginismus. This pain can keep patients from 
engaging in penetrative intercourse all together. In women over the age of 49 the pain may be 
related to menopausal changes, such as reduced estrogen and vulvovaginal atrophy[2]. 
Menopausal women are more prone to organ prolapse as well, which can alter or obstruct the 
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vaginal canal to cause pain. Childbirth and vaginal trauma can cause physical damage that alters 
the anatomy as well. Additional sources of pain may be neuropathic. There are links between 
sexual dysfunction and psychological distress as well.  
 Pregnant women can experience fluctuations in their sexual functions throughout 
pregnancy. It is estimated that the initial weeks of the first trimester and subsequent third 
trimester are the most effected by dyspareunia. Frequently this pain can reside for a year post-
partum or longer[7], but most women return to normal sexual activity within 6 months. While 
women can experience symptoms of dyspareunia during pregnancy, many studies will categorize 
this as a complication of pregnancy separate from a dyspareunia diagnosis [6]. 
 Pelvic organs outside the reproductive system can also be sources of dyspareunia. 
Gastrointestinal illnesses such as inflammatory bowel diseases and irritable bowel syndrome are 
linked to dyspareunia[2, 8]. The bladder should also be considered as a source of pain. 
Conditions such as interstitial cystitis or a urethral diverticulum cause dyspareunia in some 
women[2].  
 The treatment for dyspareunia differ depending on the etiology of the pain. Initial 
accommodations may include the use of personal lubricant or modified sexual practice to 
improve comfort. For hormonal related causes the use of hormone replacement therapies or 
topical estrogen creams are the first line therapy. It should be noted that oral contraceptives can 
also produce adverse effects that are a source of vaginal dryness and pain with intercourse 
[2].Hormonal treatments are also applicable for women suffering from endometriosis or fibroids. 
Women experiencing pain from vaginismus or primary muscular disorders may benefit from 
pelvic floor physical therapy [2, 9]. Pelvic floor therapy can be augmented with Botox injections 
into the levator muscles or electrical stimulation therapy. A final approach to treatment would 
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include surgical procedures to improve anatomical variations, such as prolapse. Sometimes 
surgery can be a source of pain, such as irritation at the vaginal cuff following a hysterectomy or 
mesh placement[2].  
 Prior studies have demonstrated links between psychiatric conditions and increased risks 
for sexual dysfunction and dyspareunia. Anxiety and depression have been associated with 
dyspareunia[9]. Several studies cite that patients who experienced prior trauma or suffered from 
post-traumatic stress disorder are at a higher risk for sexual dysfunction and pain[10]. It should 
be noted that a review of 111 articles countered this, saying that the link between sexual abuse 
and pain is weak[11]. Additionally, patients who suffer from chronic pain at an increased risk for 
sexual dysfunction and dyspareunia[12].  
 There are also socioeconomic and cultural impacts that are linked to dyspareunia. 
Women from low income backgrounds have higher rates of dyspareunia[3, 8] or sexual 
dysfunction [13, 14]. In a comparison of women from different counties in Boston, those from 
the lower-socioeconomic neighborhoods reported more issues with sexual dysfunction; however, 
they were more likely to seek medical help for their condition[15]. When looking at reproductive 
aged women, there are increased levels of dyspareunia amongst women with lower levels of 
education [3, 16, 17]. Women suffering from chronic vulvar pain only seek medical attention 
50% of the time[18] and women suffering from chronic dyspareunia seek care 28% - 40% of the 
time [5, 8]. Many of those who seek care will see 3 or more providers for care[14, 18], because 
they feel stigmatized for their condition or that they are making excuses to avoid intercourse. 
Issues like these are influencing factors that physicians should consider when evaluating patients 
for pain and sexual dysfunction. Racial differences among women with sexual dysfunction vary 
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significantly based on the study’s patient population. This will be discussed further in section 
1.3. 
 Finally, it should be noted that studies concerning sexual function are difficult to 
complete. Studies report limitations in recruitment and follow-up. Given the sensitive nature of 
the questions and exams associated with diagnosis, patients and clinicians can be hesitant to 
broach the topic of sexual function[19]. Frequently women choose to suffer in silence without 
seeking care. A study completed by Danielson[5] found that women were reluctant to discuss 
issues of prolonged and severe dyspareunia with their healthcare provider. Patients may not 
always feel comfortable broaching the topic, so it is important for health care providers to ask the 
appropriate questions about comfort during sex. For these reasons there is more research that 
needs to be done to fully understand the impact of sexual dysfunction among women.  
1.2 Evaluation of Pain and Sexual Function 
 The core of addressing sexual dysfunction and dyspareunia in patients is through 
adequate history taking. It is important to understand the location of the pain to identify 
dyspareunia versus vulvodynia. Duration and timing of the pain can also help elucidate the 
source. Pain that is linked to menstrual cycles is more evident of a problem with endometriosis 
or fibrosis. Is crucial to ask about comfort and pain with sex, because otherwise these issues may 
not be revealed in a clinical encounter otherwise[8, 19]. As already noted, there is a tendency for 
patients to not discuss their concerns about dyspareunia with their provider.  
 A physical exam can enhance the diagnosis. There may be signs of prior trauma or 
physical changes to the anatomy that can indicate potential problems with pain with intercourse. 
On the exterior clinicians should note evidence of dermal changes, such as evidence of Lichen 
sclerosis or Lichen planus, as these conditions have been linked to dyspareunia[9]. Pelvic exam 
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may also show signs of vulvovaginal atrophy, obstetrical lacerations or prolapse. On palpation of 
the uterus and ovaries there may be a detection of masses or fibroids that could be contributing to 
pain as well. Physical exam combined with thorough history should provide evidence to 
diagnose dyspareunia in a patient.  
 There are additional tools available to aid in the diagnosis of sexual dysfunction. Surveys 
are popular tools to identify issues with sexual function[20]. Past studies have used 
questionnaires to provide anonymous and safe mediums for patients to report issues of sexual 
health and function. The Female Sexual Function Index is one such survey that has been 
validated for use in evaluating sexual dysfunction.  
 The questionnaire was created in 2000 by Rosen et al[16]. It was developed using a group 
of women diagnosed with sexual arousal disorder and matched group of controls. The survey 
includes nineteen questions that address sexual function domains of desire, arousal, lubrication, 
orgasm, satisfaction and pain. Each question includes a Likert-type scaled response to identify 
specific problems with sexual function. The highest score is 36 and patients scoring less than 
26.55 is indicative sexual dysfunction. Once a patient has been identified with dysfunction, then 
a closer examination of the individual domain scores can reveal sources of the problem. Lower 
scores for questions 17-19 are indicative of pain with sex; however, a validated cutoff score have 
not been set for each domain. 
 Once a patient has established issues with pain, the Visual Analogue Scale (VAS) can be 
used to measure of the severity of the pain. This measurement instrument, while subjective, has 
been shown to be valid in an array of configurations (horizontal, vertical) and with ranges of 
edits to labels and orientation of the figures [21, 22]. This makes it an excellent tool in cross-
cultural comparisons of pain. It has been previously tested in patients with endometriosis and 
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those who suffer from dyspareunia [23]. The scales frequently range from 0-10, making it easy 
to compare changes in pain levels over the course of treatment or subsequent clinical encounters. 
 A final instrument that can be utilized to assess changes in a condition is the Clinical or 
Patient Global Impression of Improvement (PGI-I)[24]. This validated tool has been shown to be 
a great estimate of improvement for patients following treatment of stress urinary incontinence 
and fibromyalgia in women [25, 26]. The scale asks patients to provide a rating of their condition 
on a scale from 1 (very much better) to 7 (very much worse), when comparing their condition to 
its original state after treatment. This type of scale is important in identifying improvement for 
subjective conditions like pain.  
1.3 Historical Studies of Race and Gynecologic Pain 
 There is limited background on the Hispanic population and dyspareunia; however, other 
studies investigating race and other gynecologic pain disorders are available. One such study 
examined how urogenital aging impacted White, Black and Hispanic women aged 45-60[27]. In 
the study they found that women from all age groups experienced issues of dyspareunia. When 
comparing the frequency between English-speaking and Spanish-speaking Latina women, a 
higher frequency in the Spanish-speaking group (21% vs 45%) reported issues with sexual 
function. They held focus groups to identify issues related to urogenital aging and several 
women said that they were reluctant to discuss these issues with their provider. The authors 
emphasized the importance that healthcare providers inquire about sexual function and pain with 
all women in this category due to the high frequency.  
 Vulvodynia can be a factor in sexual dysfunction and dyspareunia. When comparing 
menopausal women suffering from vulvodynia, findings suggest that Hispanic women and 
women from lower socioeconomic levels are at an increased risk[13, 15]. Of the women who 
7 
 
identified problems with vulvodynia, 49.9% of the Hispanic responders qualified their pain type 
as dyspareunia, while 16.7% non-Hispanic responders qualified their pain as dyspareunia in a 
study by Ngyen et al[28]. Additional studies have reported an increased prevalence of 
vulvodynia within the Hispanic subjects of their study samples as well [28, 29], supporting 
evidence that race is a risk factor for vulvodynia.  
 Prior research on vulvodynia shows an increased prevalence of dyspareunia as a 
secondary outcome measure within Hispanic study populations [13, 14]. In young women there 
is an increased incidence of new onset vulvodynia within the Hispanic populations studied by 
Reed[30]. These historical studies on vulvodynia are important when considering sexual 
dysfunction and dyspareunia. Symptoms related to vulvodynia can cause pain with intercourse or 
limit patients from engaging in sexual activities altogether[31]. For these reasons it is important 
to evaluate vulvodynia findings when considering a study on sexual function.   
1.4 Role of Language in Clinical Encounters  
 When considering how language directly impacts our ability to discuss pain management 
we can look at a study by Riffin et al on chronic muscular pain in the elderly[32]. They found 
that Hispanic patients whose primary language was Spanish were more secure in their pain 
management plan when their provider spoke Spanish with them. There was a barrier in the 
communication on the decision-making process and understating for patients whose provider 
was not competent in their language.  The presence of an interpreter made them nervous or feel 
that they must speak quickly or not as often as they wanted. Frequently encounters utilize 
makeshift interpreters that can further complicate the discussion, leading to portions of the 
translation being omitted or patients censoring themselves for privacy[33].  
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 Patients in the Riffin study also emphasized their appreciation for cultural competency 
with their physicians. They reported feeling a greater sense of empathy from their provider and 
forming a stronger patient-provider bond when they felt a cultural appreciation for their 
background. These findings are important because 1 in 5 Spanish speaking patients delay or 
avoid care because of language barriers with English speaking providers[34].   
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2 Introduction to Thesis 
 Dyspareunia is estimated to affect up to 22% of women of all ages whereas sexual 
dysfunction reaches up to 43%[1, 2]. These estimates may not capture the true prevalence of the 
condition because it frequently goes unreported by patients[35]. Problems with sexual function 
can have a great impact on a patient’s quality of life and may be related to other comorbidities. 
By not providing a diagnosis, patients miss out on opportunities for treatment and improvement 
to their daily life. For these reasons it is important to develop a better estimate of the true 
prevalence of these conditions within our patient population. 
 In the future our patient demographics are changing and becoming more diverse. By the 
year 2060 it is estimated that 28.6% of the US population will be Hispanic[36]. There is a need 
to understand how language impacts the health care experience[34] as this demographic of 
healthcare grows. This is especially true given that there is evidence for potential differences in 
sexual dysfunction within the Hispanic community compared to the Caucasian population.  
 When women are interviewed by a healthcare provider they should have a thorough 
medical and social history taken to identify potential problems with pain or sex, but sensitive 
information may not always be revealed in these discussions. Prior studies have shown 
discomfort for both the clinician and patient during these discussions[8, 19]. Consequently, these 
problems continue to go undiagnosed and untreated. For patients who speak Spanish this 
interview is frequently mediated through an interpreter. The presence of the interpreter and/or the 
proficiency in interpreting can cause additional strains in the conversation that English proficient 
patients do not experience[33]. 
 The first aim of this project is to identify the true prevalence of dyspareunia and sexual 
dysfunction among English and Spanish speaking women within our patient community. The 
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second aim of this project is to identify the rate of women from each group that discuss painful 
sex with a healthcare provider, regardless of a diagnosis for dysfunction or pain. We hypothesize 
that Spanish speaking women will have lower rates of discussion as compared to English 
speaking women.  
 The goal of this project is to identify if language is a potential barrier to women 
discussing sexual function and pain with their clinicians. If we can identify limitations in our 
healthcare delivery system, then we can improve our patient interview process, diagnose more 
cases of sexual dysfunction and provided better treatment. The goal is to improve women’s 
health for all patients and ensure that we are providing equal access to care. Our healthcare 





3.1 Study Approval 
 Our study was approved by the University of Kansas’ Institutional Review Board: IRB 
Study00141504. 
3.2 Patient Base 
 This study utilized a convenience sample, enrolling patients who presented to either the 
University of Kansas Obstetrics and Gynecology Outpatient Clinic or the JayDoc Free Health 
Clinic. All women who were between the ages of 18 and 45 were eligible to participate if they 
spoke either English or Spanish in the clinic. The age was set to focus on pre-menopausal 
women. Pregnant women were not excluded from this study, as they make up a large portion of 
the women seen by the JayDoc clinic. There are no perceived risks or harms by participating in 
the study, but it should be noted that this study does include vulnerable patient populations since 
we are enrolling minority patients and those attending a free health clinic.  
3.3 Survey Process 
 After subjects were consented they were provided a tablet to answer survey questions 
through REDCap. Spanish speaking patients received a version that was translated by a certified 
interpreter. All surveys collected were anonymous to encourage honest and complete responses 
and subjects were offered a $10 gift card to compensate them for participation.  
 The first portion of the survey collected demographic data about the patients age, race 
and language. Additional questions gathered information on their gravity and parity status, 
surgical history and presence of pain with intercourse with a corresponding VAS pain scale if 
they responded “yes” to pain.  
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 The second portion of the survey included the entire FSFI questionnaire. This contained 
19 multiple choice questions about sexual function pertaining to the past 4 weeks. For this 
section responses were optional due to the sensitive nature of the questions. 
 The final section of the survey addressed discussion of dyspareunia in clinic. The subject 
was asked if they discussed painful sex with their provider (regardless of their pain and function 
status). A follow-up question qualified who initiated the discussion. Additional questions 
regarding treatment and improvement on the PGI-I scale were prompted when the subjects 
respond “yes” to the discussion question.  
3.4 Outcome Measures and Statistical Analysis 
 The REDCap data was analyzed using SAS software (version 9.4). The prevalence of 
dyspareunia was identified for each cohort. The FSFI score was also calculated and subjects 
scoring <26.55 were identified for sexual dysfunction. Additional calculations were made to 
identify the individual 6 domain scores for all subjects. Rates of discussion, discussion-initiation 
and treatment were calculated for each cohort. Clinician-initiated discussion was considered 
positive for responses selected for either “clinician” or “both (clinician and patient)”. Additional 
analysis identified the means for the VAS and PGI-I scores as well. 
 Each of the domains was analyzed between the language groups. Associations between 
language and outcomes were assessed using the chi-square analysis and prevalence comparisons 
were completed with t-test analysis. Additional comparisons of baseline demographics were also 
completed using the same statistical techniques. A p-value of less than 0.05 was considered 





4.1 Cohort Characteristics 
 A total of 160 women were enrolled for the survey. Their demographics are reviewed in 
Table 1. Only 9 of the subjects did not complete the entire survey. Most of the surveys were 
taken at the University of Kansas Clinic compared to the JayDoc Free Health Clinic (99 vs 51). 
This trend was significant for both English and Spanish cohorts. The mean age of subjects was 
30.57, with the English-speaking cohort significantly younger than the Spanish-speaking cohort. 
The women identified their race predominantly as either White, Black or Hispanic.  
 Of those surveyed, 106 subjects were pre-menopausal, 2 were menopausal and an 
additional 48 were unsure of their fertility status. The two cohorts had a similar count of 
menopausal participants; however, the Spanish cohort had fewer pre-menopausal participants 
than the English cohort. This could be accounted by the greater number of Spanish subjects 
answering with uncertainty about their fertility status. There was no significant difference in the 
frequency of subjects who were sexually active in the past four weeks between groups.  
 Pregnancy history was significantly different between the two cohorts. More Spanish 
subjects were pregnant. Of the 38 subjects who were pregnant, those who spoke Spanish were 
later in their gestation compared to the English-speakers. Spanish-speaking women had 
significantly more pregnancies and births when comparing gestational histories with English-
speaking women. The Spanish cohort had more standard vaginal deliveries, but there was no 
significant difference between the number of Cesarean deliveries or history of other pelvic 
surgeries between groups.  
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Table 1. Subject characteristics 
 
 
4.2 Dyspareunia and Sexual Dysfunction Measures 
 A total of 60 women responded that they had experienced pain with intercourse at some 
point in their lives. When comparing the cohorts in Table 2, significantly more English-speakers 
responded to having pain with sex. Of those women who experienced pain, the mean VAS score 
was 5.35 and there was no significant difference in VAS scores between cohorts.  
 Of the women who completed the survey, 102 English-speaking women and 50 Spanish-
speaking women had complete FSFI questions for analysis.  The average FSFI score was 21.51, 
with a significantly lower score in the Spanish cohort. Overall 51.88% of respondents had a 
15 
 
score below 26.55, which qualified as sexual dysfunction. This was significantly greater in the 
Spanish cohort as well.  
 
Table 2. Main outcome measures 
 
 
 The FSFI score can be broken down into 6 domains. Table 2 shows that the domain 
scores were significantly lower for all categories in the Spanish cohort except for satisfaction. 
The mean domain score for both languages is shown in Figure 1. Figure 2 presents the same 
data, but only includes subjects with overall dysfunctional FSFI scores (n=83). When functional 
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subjects are excluded from the data-set then there is no significant difference in domain scores 
between the cohorts (p>0.05 for all domains in Figure 2).  
 
 


















Figure 2. Mean FSFI domain scores for subjects where FSFI score is <26.55 
 
4.3 Clinical Discussion and Outcomes 
 Only 25 subjects reported discussing painful sex with a healthcare provider, as shown in 
Table 2. This was significantly higher among English-speakers compared to Spanish-speakers. 
For English patients this discussion was initiated by a clinician 13 times and for Spanish patients 
this only occurred 2 times. For the 3 Spanish-speakers who reported discussing painful sex in 
clinic, 100% of those encounters utilized an interpreter.  
 Of the 25 survey participants who discussed painful sex with their healthcare practitioner, 
13 reported that they received treatment. Of the remaining subjects, 6 reported they did not 

















difference in treatment rates between cohorts. The mean PGI-I score was 2.85, for those who did 
receive treatment, with no significant differences between groups.  
4.4 Comparison of Main Outcomes Among Hispanic Subjects  
 Table 3 depicts the primary outcome measurements for all subjects who identified as 
Hispanic race. For this subgroup the trends for subjective dyspareunia and discussion matched 
with the entire cohort: a significantly higher amount of English speaking subjects identified pain 
with sex and discussed the pain with a clinician. There is a larger proportion of Spanish-speakers 
with a dysfunction FSFI score, but unlike the overall trend, this is not significant (0.08).  
 
Table 3. Main Outcomes for Hispanic Subjects 
 
 
4.5 Comparison of Sexual Activity Among All Subjects 
 A total of 153 subjects completed the question on sexual activity in the past four weeks. 
Table 4 compares the prevalence of dyspareunia and sexual dysfunction among those who were 
sexually active and those who were not, independent of language. A larger percentage of the 
sexually active women reported having problems with painful intercourse. A significantly larger 
percentage of the sexually inactive women scored below 26.55 of the FSFI, resulting in a 
dysfunctional score.  
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Table 4. Sexual activity comparisons 
 
 
4.6 Comparison of Pregnancy Among All Subjects 
 Table 5 compares the sexual activity, prevalence of dyspareunia and sexual dysfunction 
among pregnant and non-pregnant subjects, independent of language. There was no significant 
difference in the frequency of sexual-activity among pregnant and non-pregnant women. More 
non-pregnant women reported problems with painful intercourse compared to the pregnant 
women.  There was no difference in the percentage of non-pregnant and pregnant women scoring 
under 26.55 on the FSFI. 
 
Table 5. Pregnancy comparisons 
 
 
4.7 Comparison of Locations for Survey Administration 
 Clinical outcomes of discussion and treatment were compared for both survey location 
sites in Table 6. There were no significant differences in discussion rates or discussion initiation 
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between the University of Kansas clinic (KU) and the JayDoc clinic. Interpreter use was not 
affected by location and neither was treatment. 
 






 We present a cross-sectional survey of 160 women presenting to the University of Kansas 
affiliated outpatient clinics. This descriptive study provided prevalence of dyspareunia and 
sexual dysfunction and rates of discussing pain with a clinician among English and Spanish-
speaking women within our patient population. We hypothesized that Spanish-speaking women 
would have lower rates of discussing painful sex with healthcare practitioners as compared to 
English-speaking women. Overall, we found the prevalence of sexual dysfunction to be 
significantly greater in our Spanish cohort. The prevalence of both dyspareunia and the rate of 
discussion about dyspareunia were significantly higher in the English cohort compared to the 
Spanish. Our findings for sexual dysfunction within the English cohort are consistent with 
estimates in literature, but the other prevalence findings are elevated compared to prior estimates 
for the United States. The rates of discussion support our hypothesis and our results indicate a 
need for further research on healthcare communication about sexual function.   
 This is the first study to directly compare English and Spanish-speakers in the context of 
sexual function and dyspareunia or to assess discussion of sexual pain in clinic. We found that 
English-speakers have significantly higher rates of discussion about painful sex with their 
healthcare providers than Spanish-speakers. We believe this supports our idea that language 
provides a barrier to clinicians and patients discussing sensitive issues, such as sexual function, 
during encounters. When analyzing for discussion initiation we found no difference between 
cohorts.  
 Due to these results it is unclear if the language difference is more of a barrier to the 
patient or the clinician for discussing sexual function and pain. The significant presence of the 
interpreter in Spanish encounters shows that clinicians are utilizing tools to communicate more 
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efficiently. This could also hinder communication by impacting the privacy of sensitive topics 
and limiting discussion of sexual function [32, 33]. If the interpreters used are not proficiently 
trained it could also result in information omission during translation[33], creating missed 
opportunities for accurate diagnosis and treatment. Overall, this component of the data analysis 
is difficult to draw conclusions from due to the small number of positive survey responses 
provided, especially for the Spanish cohort. The comparison of treatment between groups is 
limited by the small sample size as well.  
 The prevalence of dyspareunia and sexual dysfunction is discordant for the Spanish 
cohort. They have a lower frequency of dyspareunia when asked subjectively about pain with 
sex; however, their mean FSFI scores are significantly lower in the category of pain and they had 
significantly greater percentage of dysfunctional scores overall. In prior validation studies of the 
FSFI, patients with diagnosed vaginismus who suffered from sexual pain had lower scores across 
all domains compared to controls, with their lowest score within the pain domain[20]. This 
scoring pattern was significant for pain-based sexual dysfunction. The pattern seen in our cohort 
suggests the Spanish subjects with a dysfunctional FSFI score and a low pain domain scores may 
have not answered the subjective dyspareunia score with a positive response. Women suffering 
from dyspareunia may continue to engage in sexual activity[37]. If this is true, this indicates a 
different perspective on sex and reporting symptoms within the Spanish speaking community. 
 Differing cultural perspectives on sex, rather than language, could impact the way they 
respond to the sex-based questionnaires. When we analyzed the data for the Hispanic subgroup 
the same trends held true. The only variation was that the significant difference in sexual 
dysfunction between languages was lost, but there was still a higher proportion of Spanish-
speakers with dysfunction scores on the FSFI. This pattern indicates that the Hispanic subgroup 
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responded similarly to the overall cohorts. To understand the relationship between race, language 
and sexual health we need to complete more focused research. Since many clinicians utilize 
surveys to collect sexual health information in clinic[20] there is a need to further understand this 
dynamic, so we can tailor sexual health to each patient’s cultural needs.   
 Overall the prevalence for both sexual dysfunction and dyspareunia exceeded the 
estimates found in literature. International research on dyspareunia has reported prevalence as 
high as 54.5% in the women aged 15-49[3]. Other studies have argued that the true prevalence is 
unknown[8]. There is the potential for the condition to go undiagnosed, with only 28% seeking 
medical condition for severe and persistent cases[5]. For our study, an increase in the prevalence 
could be due to the number of participants who were not sexually active for the past 4 weeks. 
The subjective questions asked patients if they “had ever had problems with pain during sex”; 
however, the FSFI qualifies all questions for the duration of the past 4 weeks. Including 
participants who are not sexually active can bias the results to have higher levels of dysfunction.  
 Historic analysis of FSFI scores that excluded all sexually inactive subjects showed a 
higher intercorrelation among the FSFI dimensions when a subject responds with 8 or more “0” s 
(0 is the response for no sexual activity)[38]. Due to these findings it was recommended using 8 
“0” responses as a cutoff for inclusion in FSFI analysis. In a review of our responses we found a 
significant correlation between sexual activity and dysfunctional scores. More of the inactive 
responders received dysfunctional scores compared to the sexually active participants. There was 
no significant difference when comparing these groups on their subjective responses for 
dyspareunia. When we only look at the sexually active participants, our prevalence for 
dysfunction matches estimates from the literature. It is important to consider why the subjects 
refrained from sexual activity for the past 4 weeks, since pain can impact sexual activity.  
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 We completed additional analysis to identity if pregnancy impacted our prevalence 
measures. Pregnant women were not excluded from this study because they are a large portion of 
the JayDoc patient base. Additionally, many pregnant women remain sexually active and pain 
can impact their quality of life like non-pregnant women. It is known that sexual function 
fluctuates throughout the pregnancy and post-partum period for most women[7]. It is estimated 
that 17-36% of women experience dyspareunia up to six months post-partum [39]. Our results 
showed that there was no significant difference in the sexual activity or FSFI scores between 
pregnant and non-pregnant subjects. There was a significantly higher amount of non-pregnant 
women who reported painful intercourse compared to the pregnant women. For those reasons we 
justify the inclusion of pregnant women in the overall cohort for the study. 
 A final comparison was made to evaluate the differences between our survey locations. 
The University of Kansas Clinic was staffed exclusively with healthcare providers specializing in 
women’s health, whereas the JayDoc Free Health Clinic is staffed by physicians from a range of 
specialties and backgrounds. Additionally, many of the patients at JayDoc come for specialty 
nights that focus care for obstetrics, diabetes or dermatology. Due to these differences between 
clinics it was important to compare the clinical outcomes between the locations. Those analysis 
demonstrate no significant differences in care between the clinics. This supports the comparison 
of discussion rates and treatment for subjects from both locations. 
 Ultimately the findings from our study indicate that there is a higher prevalence of 
dyspareunia and sexual dysfunction among our entire patient population than expected. 
Regardless of the language all clinicians should be inquiring about their patients’ sexual function 
and potential problems with painful sex. Of the 13 respondents who received treatment for 
dyspareunia, there was an improvement as shown by the mean PGI-I score of 2.85. This score 
25 
 
translates to a response between “much better” and “a little better”. If clinicians can adequately 
diagnose and treat dyspareunia, then there is an ability for the patient to improve sexual function 
and impact their quality of life. This type of care needs to be extended to all our patients, 
especially for non-English speaking patients, since the discussion rates were lower in our 
Spanish cohort. This study was unable to identify specific breakdowns in this communication 
and future research is needed to further understand this lapse in care.  
5.1 Limitations 
 The greatest limitation of this study was the sample size. The goal of 200 participants has 
not yet been reached and several of the measured outcomes had less than 5 responses, making 
statistical comparisons difficult. Due to the sensitive nature of the questions in the FSFI we had 
to make that portion of the survey optional and we were not able to obtain complete responses 
from all subjects. Nearly one third of responders were not sexually active. This skewed the 
scores for the FSFI, which could not be accounted for in our approach to comparing groups. 
Standardization for survey administration should be implemented as well. Subjects completed 
the questionnaire before or after their clinical encounter depending on the timing of clinic flow. 
Patients completing the survey after speaking with their clinician may have a recall bias 
compared to subjects who finished the survey before their encounter. There may be an additional 
bias for subjects who did not meet with a gynecology specialist during their encounter. Finally, 
this study used a convenience sample approach and was limited to University of Kansas 
affiliated clinics. Therefore, it is a descriptive study and the results are not generalizable to the 
entire population. It should also be noted that this survey measured subjective responses that 
varied by language and are not direct, clinical measurements. This data should be treated as pilot 
data for future research and clinical considerations. 
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5.2 Considerations for Future Research 
 The goal of this study was to survey 100 women in each language group. This research is 
continuing with additional surveys in the Spanish community to reach the goal number of 
subjects. Additional surveys may be administered to obtain 200 completed surveys for optimized 
data analysis with fewer missing observations. If the finalized data analysis supports our interim 
results, showing a lower rate of discussion among Spanish speaking patients and their clinicians, 
then more research should be conducted to expand on these findings. More qualitative methods 
could be introduced to identify specific barriers in communication, such as focus groups with 
Spanish speaking women and clinicians or more surveys and interviews tailored to details of 
communication. The aim of this project was to identify barriers to care for women’s health and 
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